← Back to Search

Wearable Cardioverter Defibrillator

P-WCD for Cardiac Arrest

N/A

Waitlist Available

Led By Roxana Mehran, M.D.

Research Sponsored by Element Science, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up prescription period (~40 to 90 days, anticipated)

Awards & highlights

Study Summary

This trial looks at whether the Jewel P-WCD can help prevent sudden cardiac arrest in people at high risk for the condition.

Eligible Conditions

Sudden Cardiac Arrest

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ prescription period (~40 to 90 days, anticipated)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~prescription period (~40 to 90 days, anticipated)

This trial's timeline: 3 weeks for screening, Varies for treatment, and prescription period (~40 to 90 days, anticipated) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cutaneous Adverse Device Effects

Inappropriate Shock Rate

Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

2022

N/A

~330

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Element Science, Inc.Lead Sponsor

1 Previous Clinical Trials

18 Total Patients Enrolled

1 Trials studying Sudden Cardiac Arrest

18 Patients Enrolled for Sudden Cardiac Arrest

Roxana Mehran, M.D.Principal InvestigatorIcahn School of Medicine at Mount Sinai

John Hummel, M.D.Principal InvestigatorOhio State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open for this research endeavor?

"That is correct. According to the information on clinicaltrials.gov, this trial posted on December 1st 2022 is actively seeking participants and was recently updated in May 26th 2022. 290 individuals across a single site must be recruited for it to proceed."

Answered by AI

What is the participant capacity for this experimental research?

"Affirmative, the information hosted on clinicaltrials.gov suggests that this examination is actively recruiting test subjects. It was first published on December 1st 2022 and revised lastly on May 26th of the same year. The study seeks to enrol 290 participants in a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Jewel IDE Study

2022. "The Jewel IDE Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05201495.